Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
KU Leuven · SIB Swiss Institute of Bioinformatics · +20 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,136
total citations
- FWCI
- 69.27
- Percentile
- 100%
- References
- 34
Citations per year
Authors
37Topics & keywords
Topics
Keywords
- KRAS
- Cetuximab
- Neuroblastoma RAS viral oncogene homolog
- Medicine
- Colorectal cancer
- Oncology
- Chemotherapy
- Internal medicine
No related works found for this paper.